Articles tagged with Parkinsons Disease
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A study found that reducing TET2 activity protects neurons from inflammatory insults and neurodegeneration in Parkinson's disease. The research suggests calming TET2 activity could be a powerful preventative measure to delay or prevent symptom onset.
Research finds concussion associated with increased risk of developing ADHD, mood and anxiety disorders, dementia and Parkinson's disease. Concussions upsets brain function and blood flow, potentially leading to long-term consequences.
SpeechVive, a Purdue University-affiliated medical device company, has secured a convertible note to scale its business and expand access to its wearable device for treating Parkinson's disease. The funding will allow the company to pursue reimbursement from Medicare and commercial insurance companies.
A new study published in Neurology suggests that deep brain stimulation for Parkinson's disease does not significantly increase the risk of developing dementia. Researchers found that factors such as age, hallucinations, and cerebral hemorrhage during surgery were associated with a higher risk of dementia.
A five-year outcomes study of 30 patients found that early-stage deep brain stimulation (DBS) decreased the risk of disease progression and polypharmacy compared to optimal medical therapy alone. The study showed significant improvements in motor symptoms, with DBS patients requiring less medication for symptom management.
Researchers successfully tested an automated device for Parkinson's disease stage discrimination in individuals who cannot walk without support. The study concludes that automation can be achieved, offering improved accuracy and increased accessibility for patients with gait disorders.
A single treatment inhibiting PTB converts astrocytes into dopamine-producing neurons, restoring dopamine levels and eliminating Parkinson's disease symptoms in mice. The study provides a proof of concept for a new therapeutic approach.
The Parkinson's Foundation has awarded nearly $30,000 in grants to three nurses who specialize in Parkinson's care. The grant recipients will launch individual projects to improve life for people with Parkinson's disease in their local community.
Researchers developed a novel dietary silicon-based antioxidant agent that suppressed the development and progression of kidney failure and Parkinson's disease in rodents. The agent enabled the continuous production of an OH-eliminating molecule, significantly lowering oxidative stress and inflammation.
The Phase 1 trial demonstrated that repeated immunisation with PD01A is safe and well-tolerated, with a substantial reduction in alpha-synuclein oligomers and stable motor scores. The results suggest that PD01A may offer a promising strategy for long-term management of Parkinson's disease.
A study by Haydeh Payami and colleagues identifies a significant overabundance of opportunistic pathogens in the guts of persons with PD, compared to control subjects. The findings suggest that these microbes may play a role in triggering the disease, but more research is needed to confirm this association.
A new study by UCSF researchers found that weaker or irregular circadian rhythms in daily rest and activity cycles are associated with a greater likelihood of developing Parkinson's disease later on. Disruptions in the brain's internal clock may be an early warning sign of neurodegenerative disease processes.
A study of 3,000 independently living older men found that weak or irregular circadian rhythms are associated with a greater likelihood of developing Parkinson's disease years later. The researchers suggest that these disruptions may reflect neurodegenerative processes already affecting the brain's internal clock.
Researchers at UT Southwestern Medical Center have developed new MRI techniques to more precisely target brain structures linked to Parkinson's disease and essential tremor. These methods, including diffusion tractography, aim to reduce adverse effects associated with previous treatments.
Researchers at McLean Hospital identified two molecules naturally produced by the body that stimulate dopamine production, which may help reverse Parkinson's disease progression. Prostaglandin A1 and E1 protect dopamine-producing neurons from dying and increase dopamine levels without side effects.
A team of researchers has identified potential new therapeutic targets to treat Parkinson's disease by understanding the structure and dynamics of the protein alpha-synuclein. They found that a specific region of the protein becomes more exposed when it aggregates, which can lead to diseases like Parkinson's.
A study by NTU Singapore-Harvard University has identified a promising molecular pair, Prostaglandin E1 and Prostaglandin A1, that can boost dopamine levels and slow Parkinson's disease. The researchers found that these hormone-like substances can activate Nurr1, leading to increased dopamine production and neuroprotection.
A new UCLA study found that chemicals in diesel exhaust can trigger the toxic buildup of alpha-synuclein proteins in brain cells, a common occurrence in people with Parkinson's. The research used zebrafish and human cells to confirm the link between air pollution and brain damage.
A team of investigators from McLean Hospital and Massachusetts General Hospital have successfully reprogrammed a patient's skin cells to replace lost brain cells in Parkinson's disease. The patient has shown significant improvements in daily activities and quality of life after receiving the treatment, which involves transplanting repl...
Neuroscientists at York University developed five predictive models using non-motor clinical and biological variables to detect early-stage Parkinson's disease. The models achieved over 80% accuracy in distinguishing early-stage Parkinson's from healthy controls, offering a potential alternative to traditional diagnosis methods.
A new multi-arm, multi-stage (MAMS) trial platform is proposed to evaluate potential therapies for Parkinson's disease, potentially accelerating the search for a cure. This approach has already been successful in other diseases, such as prostate and renal cancer, and could speed up trials by eliminating unsuccessful treatments early.
Analysis of participants in the Harvard Biomarkers Study reveals an inverse association between low caffeine consumption and higher urate levels with reduced risk of Parkinson's disease. The study suggests that both caffeine and urate possess neuroprotective properties, raising potential for disease-slowing effects.
Researchers have developed a method of lymphocytic vaccination to counter autoimmune diseases, proving clinically effective in treating multiple sclerosis and rheumatoid arthritis. The technology involves creating an immunology cell bank to enhance immunological protection against infection.
Researchers have identified RasGRP1 as a key cause of Parkinson's dyskinesia, a debilitating side effect of dopamine replacement therapy. Inhibiting RasGRP1 production in the brain can diminish involuntary movements without negating the useful effects of dopamine therapy.
Researchers identified two distinct protein shapes associated with Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. The discovery may lead to improved diagnosis and treatment of these age-related conditions.
Researchers at Duke University have successfully treated motor dysfunction in an animal model of Parkinson's disease using light-based deep brain stimulation. The technique, which targets specific neurons, shows promise for tailoring therapies to individual patients and improving treatment outcomes.
Researchers have mapped out cell types behind various brain disorders, including Parkinson's disease, indicating that the disease may start in the gut. Oligodendrocytes were found to be affected early on, suggesting they play a key role in the early stages of the disease.
Researchers found signs of autoimmunity in Parkinson's patients years before diagnosis, providing potential for early detection and treatment. The study also showed that immune responses change over time, with more aggressive cells initially causing damage.
Researchers used network pharmacology to analyze Zhichan powder's effects on Parkinson's disease, identifying 18 major active components. This study provides new insights into the mechanism of action of Traditional Chinese Medicine prescriptions.
Researchers found epigenetic differences between brain hemispheres linked to variations in gene activity, making one side more vulnerable to neurological diseases. These findings could lead to new therapeutic strategies for treating Parkinson's and other neurological disorders.
Researchers have identified ATP10B as a novel risk gene for Parkinson's disease, revealing its role in transporting glucosylceramide, a lipid critical to the disease's pathogenesis. Mutations in this gene can lead to neuronal loss and increased sensitivity to environmental risk factors.
A Rutgers University study found that cognitive behavioral therapy can help alleviate depression and improve quality of life for people with Parkinson's disease. The treatment was individually tailored to target negative thoughts and behaviors, resulting in improved mental health status for 40% of participants.
A study published in Neurology found that phone-based cognitive-behavioral therapy significantly improves depression, anxiety, and quality of life in people with Parkinson's disease. After three months of weekly sessions, participants showed a significant reduction in depression symptoms and maintained improvements six months later.
Researchers found no significant difference in Parkinson's disease progression between those taking isradipine and placebo. Despite its neuroprotective properties in animal models, the study didn't support the hypothesis that isradipine slows early-stage Parkinson's progression.
Researchers developed a novel technique to study how deformed microtubules affect their function, shedding light on traumatic brain injuries and Parkinson's disease. Microtubules, like train tracks, transport molecular cargo, but become deformed in certain diseases.
Researchers found that natural killer cells can regulate and restrain inflammation of brain tissue, reducing protein clumping and viral resistance. The study suggests NK cells play a critical role in protecting against Parkinson's disease progression.
Researchers discovered a link between Parkinson's and reduced activity of a gene targeted by blue-green algae neurotoxin. This finding highlights the potential role of environmental toxins in neurodegenerative diseases like Parkinson's.
A study published in Neurology found that 82% of people with Parkinson's reported one or more eye problems, compared to 48% without the disease. Eye problems often interfered with daily life for 68% of those with Parkinson's, affecting activities like driving and reading.
Researchers investigated the association between stress-related disorders and neurodegenerative diseases in Sweden's national health registers. Stress-related disorders were found to be associated with an increased risk of these diseases.
Researchers discovered a new master control region in alpha-synuclein protein that controls amyloid formation, leading to neurodegeneration and movement difficulties. This finding opens up new opportunities to develop therapies to slow down or prevent Parkinson's disease.
A preliminary study found that Rock Steady Boxing participants reported significant improvements in quality of life areas, including depression, fatigue, and fear of falling. The program also boosted confidence in exercising, with current participants scoring better on standardized scales than non-participants.
A study found that NLX-112 reduced dyskinesia and improved movement symptoms in marmosets with Parkinson's-like symptoms. The results suggest that the drug has potential as a future treatment for people with Parkinson's, offering hope for those affected by debilitating movement problems.
Researchers used gene-editing tools to introduce the Parkinson's mutation into marmoset monkey stem cells, creating a primate model for studying disease progression and testing therapies. The edited cells exhibited characteristics of Parkinson's, such as abnormal cellular chemistry and reduced connections with neighboring neurons.
People with mild to moderate Parkinson's disease showed significant improvements in speech, handwriting, and motor skills after playing pingpong once a week for six months. The study found that participants experienced reductions in symptoms such as tremors, rigidity, and balance problems.
A new study by UCL researchers has found a link between iron accumulation in the brain and cognitive decline in people with Parkinson's disease. The study used advanced MRI techniques to detect iron deposits in different brain regions, revealing associations with poor memory and thinking scores.
Researchers have successfully solved the structure of Parkinson's disease-related protein LRRK2 inside cells using a pioneering technique. The study reveals that pathogenic LRRK2 forms exquisitely-organized double-helices around microtubules, suggesting a potential target for therapies.
Researchers have discovered a promising molecule, BT13, that may slow or stop Parkinson's disease. By increasing dopamine levels and protecting brain cells, BT13 has shown promise in treating the condition.
Researchers at Trinity College Dublin have discovered that the overactive LRRK2 enzyme wreaks havoc on motor and cognitive abilities in Parkinson's disease. The team has simulated the activity of the enzyme in the laboratory, visualizing its effects on protein complexes and paving the way for new treatments.
A long-term study of 200,000 long-distance skiers found they were almost 30% less likely to develop Parkinson's disease. This 'motor reserve' dissipates with time and age.
A randomized clinical trial found that outpatient palliative care was associated with better patient and caregiver outcomes for patients with Parkinson disease. The study included 210 patients and 175 caregivers and examined the effects of palliative care on quality of life, mood, and sleep.
Researchers have developed a technology that can distinguish between Parkinson's disease and multiple system atrophy with high accuracy. The Protein Misfolding Cyclic Amplification (PMCA) test targets misfolded alpha-synuclein aggregates, allowing doctors to identify the correct disease and pursue timely treatment.
Researchers found that people with Parkinson's carrying APOE4 variant experience faster cognitive decline and more severe dementia. Targeting APOE may reduce dementia risk in Parkinson's patients.
A Danish registry study found a significant association between neurological disorders, including dementia and Parkinson's disease, and increased risk of suicide. The study analyzed nearly 40 years of data for 7.3 million people, revealing that those with neurological conditions were more likely to die by suicide.
A recent study by KU Leuven researchers has discovered a link between a defective ATP13A2 gene and cell death in Parkinson's disease. The study found that the gene plays a crucial role in transporting polyamines, essential molecules supporting various cellular functions.
The Parkinson's Foundation has awarded a total of $30,000 to three physical therapists through its new Physical Therapy Faculty Award. The award will support individual project initiatives aimed at improving life for people with Parkinson's disease, including developing academic partnerships and heart rate monitoring protocols.
A collaboration between Rutgers University and Scripps Research has led to the discovery of a small molecule that reduces α-synuclein protein levels, potentially slowing or stopping Parkinson's disease progression. This finding offers hope for early-stage patients and may be applicable to other neurodegenerative diseases like Alzheimer's.
Researchers at Cedars-Sinai Medical Center found that people with Parkinson's disease before age 50 were born with disordered brain cells. The study suggests a potential new treatment using PEP005, which reduced alpha-synuclein levels and countered abnormal enzyme activity in dopamine neurons.
A study published in Environmental Health found a link between air pollution from traffic and an increased risk of developing dementia, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. Living near green spaces appears to have protective effects against these neurological disorders.
Researchers at Cold Spring Harbor Laboratory have developed a chemical compound, UBP1700, that inhibits certain NMDARs while allowing others to function. This allows for the precise investigation of NMDAR activity in both healthy and diseased brains.
Scientists have discovered a non-invasive technique that can successfully target both cholinergic and dopaminergic neurons, two major neurotransmitter systems affected by Parkinson's disease. This breakthrough could lead to a more precise and effective treatment for the condition.